News
Here are six new shortages and discontinuations for April, according to drug supply databases from the FDA and the American ...
Patients on kidney dialysis reported better adherence to an investigational phosphate-binding agent designed to be smaller, ...
None of the available data indicated a drug–nutrient interaction between lanthanum and continuous ... Alternatively, calcium carbonate suspension can be used (grade 2C).
OLC is being developed as a more patient-friendly alternative to Takeda's phosphate binder Fosrenol (lanthanum carbonate), which is sold in a large chewable tablet formulation, while other drugs ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results